{"id":2218,"date":"2020-05-06T16:30:51","date_gmt":"2020-05-06T20:30:51","guid":{"rendered":"https:\/\/bridgebioprod.wpengine.com\/?p=2218"},"modified":"2022-06-23T10:54:33","modified_gmt":"2022-06-23T14:54:33","slug":"bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/","title":{"rendered":"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference"},"content":{"rendered":"\r\n<p>PALO ALTO, Calif., May 6, 2020 \u2013 BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).<\/p>\r\n\r\n\r\n\r\n<p>The presentation will be webcast live and can be accessed at\u00a0<a href=\"http:\/\/bridgebio.com\/\"><strong>www.bridgebiodev.wpengine.com<\/strong><\/a>\u00a0on the\u00a0<em>For Investors<\/em>\u00a0page under\u00a0<em>News &amp; Events.<\/em>\u00a0The webcast will be available for replay through August 12, 2020.<\/p>\r\n\r\n\r\n\r\n<p><strong>About BridgeBio<\/strong><br \/>BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio\u2019s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.<\/p>\r\n\r\n\r\n\r\n<p>Investor Contact:<br \/>John Grimaldi, Burns McClellan<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iuCth1bTiuYavvzcBQjpcqvJ9Jwe42r8jyDuW5CWNhEaHnr9xGZrfHVuiufK4gXJ19DhGCVDXs-lHR4knFiGCuUUhUevwwQKkBrBdOzlh6Y=\" target=\"_blank\" rel=\"noreferrer noopener\">jgrimaldi@burnsmc.com<\/a><br \/>212-213-0006 ext. 362<\/p>\r\n\r\n\r\n\r\n<p>Media contact:<br \/>BridgeBio Pharma, Inc.<br \/>Grace Rauh<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EWYCdvqfLyG_K0QTU2AJ2sVtp8YY-vj_5HmQai_GaHEwIGjMDu5y6Rtb4hDeKquHMN06Th-qe0lIbxII6KhoNzkfAWEaTG27GijiYWds_QM=\" target=\"_blank\" rel=\"noreferrer noopener\">Grace.rauh@bridgebiodev.wpengine.com<\/a><br \/>(917) 232-5478<\/p>\r\n\r\n\r\n\r\n<p>Source: BridgeBio Pharma, Inc.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., May 6, 2020 \u2013 BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET). The presentation will be webcast live and can be accessed at\u00a0www.bridgebiodev.wpengine.com\u00a0on the\u00a0For Investors\u00a0page under\u00a0News &amp; Events.\u00a0The webcast will [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-2218","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":{"external_link":"","presentation":"","meta_short_title":"BridgeBio To Present At Upcoming Investor Conference","meta_description":"","meta_share_image":false,"people":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Investor Conference | 5\/6\/20 | BridgeBio<\/title>\n<meta name=\"description\" content=\"BridgeBio announced that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investor Conference | 5\/6\/20 | BridgeBio\" \/>\n<meta property=\"og:description\" content=\"BridgeBio announced that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-06T20:30:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-23T14:54:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Brandon Keller\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brandon Keller\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/\",\"url\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/\",\"name\":\"Investor Conference | 5\/6\/20 | BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2020-05-06T20:30:51+00:00\",\"dateModified\":\"2022-06-23T14:54:33+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325\"},\"description\":\"BridgeBio announced that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325\",\"name\":\"Brandon Keller\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g\",\"caption\":\"Brandon Keller\"},\"url\":\"https:\/\/bridgebio.com\/author\/bkeller\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investor Conference | 5\/6\/20 | BridgeBio","description":"BridgeBio announced that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/","og_locale":"en_US","og_type":"article","og_title":"Investor Conference | 5\/6\/20 | BridgeBio","og_description":"BridgeBio announced that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).","og_url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/","og_site_name":"BridgeBio","article_published_time":"2020-05-06T20:30:51+00:00","article_modified_time":"2022-06-23T14:54:33+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Brandon Keller","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Brandon Keller","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/","url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/","name":"Investor Conference | 5\/6\/20 | BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2020-05-06T20:30:51+00:00","dateModified":"2022-06-23T14:54:33+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325"},"description":"BridgeBio announced that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).","breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/6cd954001e2cec42c2e8290f7c570325","name":"Brandon Keller","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3f5f406075c438807a4d70dccadd771a?s=96&d=mm&r=g","caption":"Brandon Keller"},"url":"https:\/\/bridgebio.com\/author\/bkeller\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/2218"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=2218"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/2218\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=2218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=2218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=2218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}